Ciprofloxacin vs Ipilimumab

Ciprofloxacin vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Ciprofloxacin and Ipilimumab.

Mechanism of Action

Ciprofloxacin: Inhibits bacterial DNA gyrase and topoisomerase IV.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Ciprofloxacin — 4 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Ciprofloxacin — C17H18FN3O3.

Molecular Weight: Ciprofloxacin — 331.3460 g/mol.

Type: Ciprofloxacin — Small molecule; Ipilimumab — Antibody.